Curative thoraco-systemic therapy plus local treatment to the brain for extensive disease-small-cell lung cancer with metastasis only to the brain

We reviewed 11 cases of extensive disease (ED)-SCLC and metastasis only to the brain treated during 2011-14. All patients underwent definitive therapy similar to that for limited disease (LD), combined with local treatment for BM. We compared the survival outcomes of these patients to those of patie...

Full description

Saved in:
Bibliographic Details
Published in:Japanese journal of clinical oncology 2019-07, Vol.49 (7), p.687-690
Main Authors: Shibata, Kazuhiko, Iwasa, Keiichi, Takanaka, Tsuyoshi, Yachi, Tsuyoshi, Okazaki, Akihito, Shiba, Yasutaka, Kasahara, Kazuo
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c344t-e48890a485e047fc8a5416c4b6fe67f0736fba34717d78f3eb103fb72465a28b3
cites cdi_FETCH-LOGICAL-c344t-e48890a485e047fc8a5416c4b6fe67f0736fba34717d78f3eb103fb72465a28b3
container_end_page 690
container_issue 7
container_start_page 687
container_title Japanese journal of clinical oncology
container_volume 49
creator Shibata, Kazuhiko
Iwasa, Keiichi
Takanaka, Tsuyoshi
Yachi, Tsuyoshi
Okazaki, Akihito
Shiba, Yasutaka
Kasahara, Kazuo
description We reviewed 11 cases of extensive disease (ED)-SCLC and metastasis only to the brain treated during 2011-14. All patients underwent definitive therapy similar to that for limited disease (LD), combined with local treatment for BM. We compared the survival outcomes of these patients to those of patients with LD (n = 29) or other ED (n = 38) during the same period. Three patients had progression of BM at completion of chemotherapy. Ten patients received whole-brain radiotherapy (4 prophylactic, 6 therapeutic), and remaining one elderly patient underwent stereotactic radiosurgery. Finally, 8 and 3 patients achieved a CR or PR of BM, respectively. Five remained free of progression for 21.1-73.2 months. The progression-free and overall survival outcomes of ED-SCLC with brain only metastases were comparable to those of LD and superior to those of other ED. In conclusion, ED-SCLC with metastasis limited to the brain could be treated with curative intent.
doi_str_mv 10.1093/jjco/hyz079
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2232107904</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2232107904</sourcerecordid><originalsourceid>FETCH-LOGICAL-c344t-e48890a485e047fc8a5416c4b6fe67f0736fba34717d78f3eb103fb72465a28b3</originalsourceid><addsrcrecordid>eNpVkU9r3DAQxUVpaP711HvRsRCcSJZsaY9lSdpAIJfmbMbaUdeLbG01chvnY_QTx2bTksDADDOPH8N7jH2S4lKKlbra7Vy82k5PwqzesROp66pQdSnfv5qP2SnRTghRWW0-sGMlparsyp6wv-sxQe5-I8_bmMDFgibK2HduXmCC_cT3YSQeooPAc0LIPQ6Z57jceZugG7iPieNjxoEW0KYjBMKCegihcBgCD-PwkzsYHCb-p8tb3mMGmqsjHocwvcGdsyMPgfDjSz9jDzfXP9bfi7v7b7frr3eFU1rnArW1KwHaVii08c5CpWXtdFt7rI0XRtW-BaWNNBtjvcJWCuVbU86mQGlbdca-HLj7FH-NSLnpO1rehQHjSE1ZqlLOpgo9Sy8OUpciUULf7FPXQ5oaKZolhGYJoTmEMKs_v4DHtsfNf-0_19UzT2-HUg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2232107904</pqid></control><display><type>article</type><title>Curative thoraco-systemic therapy plus local treatment to the brain for extensive disease-small-cell lung cancer with metastasis only to the brain</title><source>Oxford University Press:Jisc Collections:OUP Read and Publish 2024-2025 (2024 collection) (Reading list)</source><creator>Shibata, Kazuhiko ; Iwasa, Keiichi ; Takanaka, Tsuyoshi ; Yachi, Tsuyoshi ; Okazaki, Akihito ; Shiba, Yasutaka ; Kasahara, Kazuo</creator><creatorcontrib>Shibata, Kazuhiko ; Iwasa, Keiichi ; Takanaka, Tsuyoshi ; Yachi, Tsuyoshi ; Okazaki, Akihito ; Shiba, Yasutaka ; Kasahara, Kazuo</creatorcontrib><description>We reviewed 11 cases of extensive disease (ED)-SCLC and metastasis only to the brain treated during 2011-14. All patients underwent definitive therapy similar to that for limited disease (LD), combined with local treatment for BM. We compared the survival outcomes of these patients to those of patients with LD (n = 29) or other ED (n = 38) during the same period. Three patients had progression of BM at completion of chemotherapy. Ten patients received whole-brain radiotherapy (4 prophylactic, 6 therapeutic), and remaining one elderly patient underwent stereotactic radiosurgery. Finally, 8 and 3 patients achieved a CR or PR of BM, respectively. Five remained free of progression for 21.1-73.2 months. The progression-free and overall survival outcomes of ED-SCLC with brain only metastases were comparable to those of LD and superior to those of other ED. In conclusion, ED-SCLC with metastasis limited to the brain could be treated with curative intent.</description><identifier>ISSN: 1465-3621</identifier><identifier>EISSN: 1465-3621</identifier><identifier>DOI: 10.1093/jjco/hyz079</identifier><identifier>PMID: 31135898</identifier><language>eng</language><publisher>England</publisher><ispartof>Japanese journal of clinical oncology, 2019-07, Vol.49 (7), p.687-690</ispartof><rights>The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c344t-e48890a485e047fc8a5416c4b6fe67f0736fba34717d78f3eb103fb72465a28b3</citedby><cites>FETCH-LOGICAL-c344t-e48890a485e047fc8a5416c4b6fe67f0736fba34717d78f3eb103fb72465a28b3</cites><orcidid>0000-0002-4864-5970</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31135898$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shibata, Kazuhiko</creatorcontrib><creatorcontrib>Iwasa, Keiichi</creatorcontrib><creatorcontrib>Takanaka, Tsuyoshi</creatorcontrib><creatorcontrib>Yachi, Tsuyoshi</creatorcontrib><creatorcontrib>Okazaki, Akihito</creatorcontrib><creatorcontrib>Shiba, Yasutaka</creatorcontrib><creatorcontrib>Kasahara, Kazuo</creatorcontrib><title>Curative thoraco-systemic therapy plus local treatment to the brain for extensive disease-small-cell lung cancer with metastasis only to the brain</title><title>Japanese journal of clinical oncology</title><addtitle>Jpn J Clin Oncol</addtitle><description>We reviewed 11 cases of extensive disease (ED)-SCLC and metastasis only to the brain treated during 2011-14. All patients underwent definitive therapy similar to that for limited disease (LD), combined with local treatment for BM. We compared the survival outcomes of these patients to those of patients with LD (n = 29) or other ED (n = 38) during the same period. Three patients had progression of BM at completion of chemotherapy. Ten patients received whole-brain radiotherapy (4 prophylactic, 6 therapeutic), and remaining one elderly patient underwent stereotactic radiosurgery. Finally, 8 and 3 patients achieved a CR or PR of BM, respectively. Five remained free of progression for 21.1-73.2 months. The progression-free and overall survival outcomes of ED-SCLC with brain only metastases were comparable to those of LD and superior to those of other ED. In conclusion, ED-SCLC with metastasis limited to the brain could be treated with curative intent.</description><issn>1465-3621</issn><issn>1465-3621</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNpVkU9r3DAQxUVpaP711HvRsRCcSJZsaY9lSdpAIJfmbMbaUdeLbG01chvnY_QTx2bTksDADDOPH8N7jH2S4lKKlbra7Vy82k5PwqzesROp66pQdSnfv5qP2SnRTghRWW0-sGMlparsyp6wv-sxQe5-I8_bmMDFgibK2HduXmCC_cT3YSQeooPAc0LIPQ6Z57jceZugG7iPieNjxoEW0KYjBMKCegihcBgCD-PwkzsYHCb-p8tb3mMGmqsjHocwvcGdsyMPgfDjSz9jDzfXP9bfi7v7b7frr3eFU1rnArW1KwHaVii08c5CpWXtdFt7rI0XRtW-BaWNNBtjvcJWCuVbU86mQGlbdca-HLj7FH-NSLnpO1rehQHjSE1ZqlLOpgo9Sy8OUpciUULf7FPXQ5oaKZolhGYJoTmEMKs_v4DHtsfNf-0_19UzT2-HUg</recordid><startdate>20190701</startdate><enddate>20190701</enddate><creator>Shibata, Kazuhiko</creator><creator>Iwasa, Keiichi</creator><creator>Takanaka, Tsuyoshi</creator><creator>Yachi, Tsuyoshi</creator><creator>Okazaki, Akihito</creator><creator>Shiba, Yasutaka</creator><creator>Kasahara, Kazuo</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4864-5970</orcidid></search><sort><creationdate>20190701</creationdate><title>Curative thoraco-systemic therapy plus local treatment to the brain for extensive disease-small-cell lung cancer with metastasis only to the brain</title><author>Shibata, Kazuhiko ; Iwasa, Keiichi ; Takanaka, Tsuyoshi ; Yachi, Tsuyoshi ; Okazaki, Akihito ; Shiba, Yasutaka ; Kasahara, Kazuo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c344t-e48890a485e047fc8a5416c4b6fe67f0736fba34717d78f3eb103fb72465a28b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shibata, Kazuhiko</creatorcontrib><creatorcontrib>Iwasa, Keiichi</creatorcontrib><creatorcontrib>Takanaka, Tsuyoshi</creatorcontrib><creatorcontrib>Yachi, Tsuyoshi</creatorcontrib><creatorcontrib>Okazaki, Akihito</creatorcontrib><creatorcontrib>Shiba, Yasutaka</creatorcontrib><creatorcontrib>Kasahara, Kazuo</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Japanese journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shibata, Kazuhiko</au><au>Iwasa, Keiichi</au><au>Takanaka, Tsuyoshi</au><au>Yachi, Tsuyoshi</au><au>Okazaki, Akihito</au><au>Shiba, Yasutaka</au><au>Kasahara, Kazuo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Curative thoraco-systemic therapy plus local treatment to the brain for extensive disease-small-cell lung cancer with metastasis only to the brain</atitle><jtitle>Japanese journal of clinical oncology</jtitle><addtitle>Jpn J Clin Oncol</addtitle><date>2019-07-01</date><risdate>2019</risdate><volume>49</volume><issue>7</issue><spage>687</spage><epage>690</epage><pages>687-690</pages><issn>1465-3621</issn><eissn>1465-3621</eissn><abstract>We reviewed 11 cases of extensive disease (ED)-SCLC and metastasis only to the brain treated during 2011-14. All patients underwent definitive therapy similar to that for limited disease (LD), combined with local treatment for BM. We compared the survival outcomes of these patients to those of patients with LD (n = 29) or other ED (n = 38) during the same period. Three patients had progression of BM at completion of chemotherapy. Ten patients received whole-brain radiotherapy (4 prophylactic, 6 therapeutic), and remaining one elderly patient underwent stereotactic radiosurgery. Finally, 8 and 3 patients achieved a CR or PR of BM, respectively. Five remained free of progression for 21.1-73.2 months. The progression-free and overall survival outcomes of ED-SCLC with brain only metastases were comparable to those of LD and superior to those of other ED. In conclusion, ED-SCLC with metastasis limited to the brain could be treated with curative intent.</abstract><cop>England</cop><pmid>31135898</pmid><doi>10.1093/jjco/hyz079</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-4864-5970</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1465-3621
ispartof Japanese journal of clinical oncology, 2019-07, Vol.49 (7), p.687-690
issn 1465-3621
1465-3621
language eng
recordid cdi_proquest_miscellaneous_2232107904
source Oxford University Press:Jisc Collections:OUP Read and Publish 2024-2025 (2024 collection) (Reading list)
title Curative thoraco-systemic therapy plus local treatment to the brain for extensive disease-small-cell lung cancer with metastasis only to the brain
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T03%3A44%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Curative%20thoraco-systemic%20therapy%20plus%20local%20treatment%20to%20the%20brain%20for%20extensive%20disease-small-cell%20lung%20cancer%20with%20metastasis%20only%20to%20the%20brain&rft.jtitle=Japanese%20journal%20of%20clinical%20oncology&rft.au=Shibata,%20Kazuhiko&rft.date=2019-07-01&rft.volume=49&rft.issue=7&rft.spage=687&rft.epage=690&rft.pages=687-690&rft.issn=1465-3621&rft.eissn=1465-3621&rft_id=info:doi/10.1093/jjco/hyz079&rft_dat=%3Cproquest_cross%3E2232107904%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c344t-e48890a485e047fc8a5416c4b6fe67f0736fba34717d78f3eb103fb72465a28b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2232107904&rft_id=info:pmid/31135898&rfr_iscdi=true